Global Information
회사소개 | 문의

세계의 신경자극기기 시장 예측

GLOBAL NEUROSTIMULATION DEVICE MARKET FORECAST 2017-2025

리서치사 Inkwood Research
발행일 2017년 07월 상품 코드 530650
페이지 정보 영문 162 Pages
가격
US $ 2,500 ₩ 2,870,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 되지 않으며, 인쇄 또한 불가능합니다.
US $ 3,000 ₩ 3,444,000 PDF (Multi User License) help
동일 사업장(소재지) 내 5명까지 이용가능한 라이센스입니다. PDF 파일은 Copy & Paste가 되지 않습니다. 인쇄는 1명당 1회에 한해 가능하며 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,500 ₩ 5,166,000 PDF (Enterprisewide License) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 신경자극기기 시장 예측 GLOBAL NEUROSTIMULATION DEVICE MARKET FORECAST 2017-2025
발행일 : 2017년 07월 페이지 정보 : 영문 162 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

한글목차

세계의 신경자극기기(Neurostimulation Device) 시장 전망에 대해 분석했으며, 시장의 기본 구조·배경 구조, 주요 성장 촉진·억제요인, 시장 전체 및 제품별·용도별·지역별 시장 동향 전망(향후 9년간), 현재 시장 매력도, 기업간 경쟁 동향, 주요 기업 개요 등의 정보를 전해드립니다.

제1장 분석 범위

제2장 분석 방법

제3장 주요 요약

제4장 시장 결정요인

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장이 해결해야 할 과제

제5장 시장 세분화

  • 기기별 시장 세분화(향후 9년간)
    • 척수자극기(SCS)
    • 뇌심부자극기(DBS)
    • 천수신경자극기(SNS)
    • 미주신경자극기(VNS)
    • 기타
  • 용도별 시장 세분화(향후 9년간)
    • 통증 관리
    • 간질
    • 본태성진전
    • 요실금·변실금
    • 우울증
    • 근육긴장이상
    • 위마비
    • 파킨슨병

제6장 주요 지표

  • Porter's Five Forces 분석
  • 추정 분석
    • 정신질환 유병자수 증가
    • 세계 각국에서의 의료비 확대
    • 고령자 인구 증가
  • 밸류체인 분석
    • 의약품 관련 : 제조업체, 유통업체, 소매점포, 최종사용자
    • 의료기기 관련 : 제조업체, 유통업체, 최종사용자
  • 시장 기회 매트릭스
  • 벤더 구도

제7장 지역 분석

  • 북미(미국, 캐나다)
  • 유럽(영국, 프랑스, 독일, 스페인 등)
  • 아시아태평양(인도, 중국, 일본, 호주 등)
  • 기타 국가(RoW)

제8장 기업 개요

KSM 17.08.02

영문목차

KEY FINDINGS

The global neurostimulation device market which was worth $1902 million in 2016 is anticipated to grow at a CAGR of 8.67% during the forecast period of 2017-2025. Its net worth is estimated to rise up to $4004 million by the end of 2025. The fact that these devices aid in the therapeutic activation for many neurological diseases is majorly driving the market. Other factors include the high occurrence of diseases, second-line of treatment, increased elderly populace and the various developments in technology.

MARKET INSIGHTS

The global neurostimulation device market can be segmented on the basis of the type of system and by the application type. The different type of systems can be classified as Global DBS system market, Global SCS system market, Global SNS system market, Global VNS system market and Others. The application of the neurostimulation devices can be seen in Depression market, Pain management market, Essential tremor market, Epilepsy market, Urinary and fecal incontinence market, Dystonia market, Gastroparesis market and in Parkinson's disease market. Albeit such wide range of applications, safety concerns remains to be one of the major market challenges. Patients might be at a risk of contracting infections at the time of implantation or may face issues if they are in contact with or near to electromagnetic radiation and electrical and gas-powered appliances. Also, the malfunction of the implanted device might go unnoticed by the patient leading to higher risks.

REGIONAL INSIGHTS

Geographically, the market can be divided into four major regions, which includes:

North America - U.S. & Canada

Asia-Pacific - China, India, Japan, Australia, Rest of APAC

Europe - UK, France, Germany, Spain, and Rest of Europe

Rest of World

The Asia-Pacific market is predicted to show the fastest growth over the forecast period. Factors like a large patient base and the rising investments in healthcare sectors in countries like China and Japan are proving conducive to the market growth in this region. At present, however, the North America region is leading the market scene. The United States is a major revenue contributor to the global neurostimulation device market. The North American region is expected to continue this dominance and hold the highest share by 2025 in the global market. The market is wildly attracting investors from all over the globe because of profitable aspects like advances in technology and the US government's increased focus on improving patient safety and procedure efficiency by using neurostimulation devices.

COMPETITIVE INSIGHTS

St. Jude Medical is a global medical device manufacturer that develops medical technology, products, and services for the treatment of neurological, chronic pain, and cardiac patients. Another company, Boston Scientific caters to high-quality medical devices used in the treatment of a large number of medical conditions. Medtronic Inc. manufactures and sells device-centered medicinal treatments globally along with assembling intra-operative imaging systems and image-guided surgery. It also offers web-based therapy management software solutions. The other major players in the market include Aleva Neurotherapeutics SA, Cogentix Medical Inc, Depuy Synthes Companies, Dr. Langer Medical GMBH, EBS Technologies Gmbh, Intrapace Inc, Neurological Surgery PC, Neuronetics Inc, Nevro Corp, and the Magstim Company Limited.

TABLE OF CONTENTS

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. NEUROSTIMULATION DEVICE MARKET IS GROWING AT A MODERATE RATE
    • 3.2.2. UNITED STATES IS THE MAJOR REVENUE CONTRIBUTOR
    • 3.2.3. AID IN THE THERAPEUTIC ACTIVATE

4. MARKET DETERMINANTS

  • 4.1. MARKET DRIVERS
    • 4.1.1. HIGH OCCURRENCE OF DISEASES
    • 4.1.2. DEVELOPMENTS IN TECHNOLOGY
    • 4.1.3. INCREASED POPULACE OF ELDERLY PEOPLE
    • 4.1.4. SECOND-LINE OF TREATMENT
  • 4.2. RESTRAINTS
    • 4.2.1. HIGH VALUE OF SCS DEVICE AND EARLY TREATMENT
    • 4.2.2. POSSIBLE SIDE EFFECTS OF SCS THERAPY AND COMPLICATIONS
    • 4.2.3. ANONYMOUS APPLIANCE OF SCS THERAPY
  • 4.3. OPPORTUNITIES
    • 4.3.1. DEVELOPMENT OF INDICATION FOR SCS
    • 4.3.2. REQUIREMENT FOR MRI DEVICES
    • 4.3.3. GROWING OCCURRENCE OF CHRONIC DISCOMFORT
  • 4.4. MARKET CHALLENGES
    • 4.4.1. OBTAINABILITY OF ALTERNATIVE THERAPY
    • 4.4.2. HIGH PRICE OF TREATMENT
    • 4.4.3. SAFETY CONCERNS

5. MARKET SEGMENTATION

  • 5.1. MARKET BY SYSTEM 2017-2025
    • 5.1.1. GLOBAL SCS SYSTEM MARKET
    • 5.1.2. GLOBAL DBS SYSTEM MARKET
    • 5.1.3. GLOBAL SNS SYSTEM MARKET
    • 5.1.4. GLOBAL VNS SYSTEM MARKET
    • 5.1.5. OTHERS
  • 5.2. MARKET BY APPLICATION 2017-2025
    • 5.2.1. PAIN MANAGEMENT MARKET
    • 5.2.2. EPILEPSY MARKET
    • 5.2.3. ESSENTIAL TREMOR MARKET
    • 5.2.4. URINARY AND FECAL INCONTINENCE MARKET
    • 5.2.5. DEPRESSION MARKET
    • 5.2.6. DYSTONIA MARKET
    • 5.2.7. GASTROPARESIS MARKET
    • 5.2.8. PARKINSON'S DISEASE MARKET

6. KEY ANALYTICS

  • 6.1. PORTERS 5 FORCES ANALYSIS
    • 6.1.1. THREAT OF NEW ENTRANTS
    • 6.1.2. THREAT OF SUBSTITUTES
    • 6.1.3. BARGAINING POWER OF SUPPLIERS
    • 6.1.4. BARGAINING POWER OF BUYERS
    • 6.1.5. THREAT OF RIVALRY
  • 6.2. ESTIMATION ANALYSIS
    • 6.2.1. INCREASING PREVALENCE OF MENTAL HEALTH PROBLEME
    • 6.2.2. RISING HEALTHCARE EXPENDITURE ACROSS THE GLOBE
    • 6.2.3. RISING GERIATRIC POPULATION
  • 6.3. VALUE CHAIN ANALYSIS
    • 6.3.1. FOR DRUGS
      • 6.3.1.1. MANUFACTURERS
      • 6.3.1.2. DISTRIBUTORS
      • 6.3.1.3. RETAILERS
      • 6.3.1.4. END-USERS
    • 6.3.2. FOR DEVICES
      • 6.3.2.1. MANUFACTURERS
      • 6.3.2.2. DISTRIBUTORS
      • 6.3.2.3. END-USERS
  • 6.4. OPPORTUNITY MATRIX
  • 6.5. VENDOR LANDSCAPE

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. UNITED STATES
    • 7.1.2. CANADA
  • 7.2. EUROPE
    • 7.2.1. UNITED KINGDOM
    • 7.2.2. FRANCE
    • 7.2.3. GERMANY
    • 7.2.4. SPAIN
    • 7.2.5. REST OF EUROP
  • 7.3. ASIA-PACIFIC
    • 7.3.1. INDIA
    • 7.3.2. CHINA
    • 7.3.3. JAPAN
    • 7.3.4. AUSTRALIA
    • 7.3.5. REST OF APAC
  • 7.4. REST OF WORLD

8. COMPANY PROFILES

  • 8.1. ALEVA NEUROTHERAPEUTICS SA
  • 8.2. BOSTON SCIENTIFIC CORPORATION
  • 8.3. COGENTIX MEDICAL INC
  • 8.4. CYBERONICS INC
  • 8.5. DEPUY SYNTHES COMPANIES
  • 8.6. DR. LANGER MEDICAL GMBH
  • 8.7. EBS TECHNOLOGIES GMBH
  • 8.8. INTRAPACE INC
  • 8.9. MEDTRONIC PLC
  • 8.10. NEUROLOGICAL SURGERY PC
  • 8.11. NEURONETICS INC
  • 8.12. NEVRO CORP.
  • 8.13. ST. JUDE MEDICAL, INC.
  • 8.14. THE MAGSTIM COMPANY LIMITED

TABLE LIST

  • TABLE # 1 GLOBAL NEUROSTIMULATION MARKET BY REGION 2017-2025($ MILLION)
  • TABLE # 2 GLOBAL SYSTEM MARKET 2017-2025 ($ MILLIONS)
  • TABLE # 3 GLOBAL NEUROSTIMULATION MARKET, BY APPLICATION 2017-2025 ($ MILLIONS)
  • TABLE # 4 GLOBAL NEUTRACEUTICAL DEVICE MARKET, BY REGION 2017-2025 ($ MILLION)
  • TABLE # 5 CONDITION TREATED BY NEUROSTIMULATION DEVICES IN US
  • TABLE # 6 NORTH AMERICA NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • TABLE # 7 EUROPE NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • TABLE # 8 ASIA PACIFIC NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)

FIGURE LIST

  • FIGURE # 1 GLOBAL NEUROSTIMULATION MARKET 2017-2025($ MILLION)
  • FIGURE # 2 GLOBAL SCS SYSTEM MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 3 GLOBAL DBS SYSTEM MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 4 GLOBAL SNS SYSTEM MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 5 GLOBAL VNS SYSTEM MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 6 GLOBAL OTHER SYSTEM MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 7 GLOBAL PAIN MANAGEMENT MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 8 GLOBAL EPILEPSY MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 9 GLOBAL ESSENTIAL TREMOR MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 10 GLOBAL URINARY AND FECAL INCONTINENCE MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 11 GLOBAL DEPRESSION MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 12 GLOBAL DYSTONIA MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 13 GLOBAL GASTROPARESIS MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 14 GLOBAL PARKINSON'S DISEASE MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 15 PREVALENCE OF MENTAL HEALTH DISORDERS ACROSS THE GLOBE BETWEEN PERIOD 2012 AND 2020 (MILLION)
  • FIGURE # 16 RISING GERIATRIC POPULATION ACROSS THE GLOBE FOR PERIOD 2014-2020 (MILLION)
  • FIGURE # 17 VALUE CHAIN OF ANTIDEPRESSANT DRUGS
  • FIGURE # 18 UNITED STATES NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 19 CANADA NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 20 UNITED KINGDOM NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 21 FRANCE NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 22 GERMANY NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 23 SPAIN NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 24 REST OF EUROPE NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 25 INDIA NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 26 CHINA NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 27 JAPAN NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 28 AUSTRALIA NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 29 REST OF APAC NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 30 REST OFWORLD NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
BCC Research